HopeStage
Back to all studies
RecruitingNCT05099874

Home-based attention training for children with sickle cell disease

About this titleRead the official source — NCT05099874
Device studyAges 8–16United StatesADHD
The study in practice

Understand this study

Who could participate?

Listed age limits: 8 years to 16 years.

Listed locations
Washington D.C.See all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 20, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
20
Sponsor
Children's National Research Institute
Sponsor type
Research institute
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 8 Years to 16 Years
Official registry ID
NCT05099874
Official title
Show the full official title

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

Recruitment & locations

Currently recruiting

Washington D.C.

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Children's National Research Institute, a research institute.

Who can participate?

Listed age limits: 8 years to 16 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies